Related Experiment Videos

[The effect of treatment methods on frequency of relapse in nephrotic syndrome in children]

A Goszczyk1, A Jung, V Bochniewska

  • 1Kliniki Pediatrii i Nefrologii Dzieciecej CSK WAM w Warszawie.

Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|November 18, 2000
PubMed

Insights

Treatment for childhood nephrotic syndrome impacts remission and relapse rates. Tailoring treatment to individual patient needs is crucial for managing steroid-dependent and frequently relapsing cases effectively.

Area of Science:

  • Pediatric Nephrology
  • Clinical Medicine

Background:

  • Nephrotic syndrome is a significant kidney disorder in children, characterized by proteinuria, edema, and hypoalbuminemia.
  • Steroid sensitivity is common, but frequent relapses and steroid dependence pose treatment challenges.

Purpose of the Study:

  • To evaluate how different treatment modalities influence remission duration and relapse frequency in pediatric nephrotic syndrome.
  • To analyze treatment outcomes based on disease specificity in steroid-dependent and frequently relapsing cases.

Main Methods:

  • Retrospective analysis of 26 children (aged 1-17) treated between 1993-1999.
  • Standard treatment involved intravenous hydrocortisone followed by oral prednisone per ISKDC criteria.
  • Specific interventions included intravenous methylprednisolone for steroid-dependent cases, levamisole for concurrent infections, and chlorambucil for refractory cases.

Main Results:

  • Most children (92.3%) presented with edema syndrome.
  • Only one patient remained relapse-free over 3 years, indicating a high relapse rate.
  • Intravenous methylprednisolone, levamisole, and chlorambucil were used in subgroups based on disease characteristics.

Conclusions:

  • Treatment strategies for nephrotic syndrome must be individualized, especially for steroid-dependent and frequently relapsing forms.
  • The choice of therapy should align with the specific clinical presentation and disease course of each child.
  • Further research into optimized treatment protocols for pediatric nephrotic syndrome is warranted.

Related Concept Videos

Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...